AMERICAN SHARED HOSPITAL SERVICES Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 406.00 thousand shares for the 12-month period ending 2020-12-31, per its 10-K filed 2021-04-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2021-04-06
- AMERICAN SHARED HOSPITAL SERVICES antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2020-09-30 was 10.00K shares, a 98.05% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2019-09-30 was 513.00K shares.
- AMERICAN SHARED HOSPITAL SERVICES antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2017-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2016-09-30 was 571.00K shares.
- AMERICAN SHARED HOSPITAL SERVICES antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 406.00K shares, a 4.91% increase from fiscal 2019.
- AMERICAN SHARED HOSPITAL SERVICES antidilutive securities excluded from computation of earnings per share, amount for fiscal 2019 was 387.00K shares, a 25.43% decline from fiscal 2018.
- AMERICAN SHARED HOSPITAL SERVICES antidilutive securities excluded from computation of earnings per share, amount for fiscal 2018 was 519.00K shares, a 3607.14% increase from fiscal 2017.
- AMERICAN SHARED HOSPITAL SERVICES antidilutive securities excluded from computation of earnings per share, amount for fiscal 2017 was 14.00K shares, a 97.59% decline from fiscal 2016.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2020-12-31 | 406.00K shares 10-K · filed 2021-04-06 | |||
| 2020-09-30 | 10.00K shares 10-Q · filed 2020-11-13 | 10.00K shares 10-Q · filed 2020-11-13 | ||
| 2019-12-31 | 387.00K shares 10-K · filed 2021-04-06 | |||
| 2019-09-30 | 513.00K shares 10-Q · filed 2020-11-13 | 513.00K shares 10-Q · filed 2020-11-13 | ||
| 2018-12-31 | 519.00K shares 10-K · filed 2020-04-03 | |||
| 2017-12-31 | 14.00K shares 10-K · filed 2020-04-03 | |||
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-15 | |||
| 2016-12-31 | 581.00K shares 10-K · filed 2019-03-29 | |||
| 2016-09-30 | 571.00K shares 10-Q · filed 2016-11-10 | 600.00K shares 10-Q · filed 2016-11-10 | ||
| 2016-06-30 | 605.00K shares 10-Q · filed 2017-08-10 | 627.00K shares 10-Q · filed 2017-08-10 | ||
| 2016-03-31 | 617.00K shares 10-Q · filed 2017-05-15 | |||
| 2015-12-31 | 614.00K shares 10-K · filed 2018-03-28 | |||
| 2015-03-31 | 617.00K shares 10-Q · filed 2016-05-12 | |||
| 2014-12-31 | 633.00K shares 10-K · filed 2017-03-27 | |||
| 2014-09-30 | 517.00K shares 10-Q · filed 2014-11-14 | |||
| 2014-06-30 | 513.00K shares 10-Q · filed 2014-08-15 | 513.00K shares 10-Q · filed 2014-08-15 | ||
| 2014-03-31 | 525.00K shares 10-Q · filed 2014-05-15 | |||
| 2013-12-31 | 576.00K shares 10-K · filed 2016-03-30 | |||
| 2013-09-30 | 580.00K shares 10-Q · filed 2014-11-14 | 580.00K shares 10-Q · filed 2014-11-14 | ||
| 2013-06-30 | 608.00K shares 10-Q · filed 2014-08-15 | 608.00K shares 10-Q · filed 2014-08-15 | ||
| 2013-03-31 | 592.00K shares 10-Q · filed 2014-05-15 | |||
| 2012-12-31 | 588.00K shares 10-K · filed 2015-04-01 | |||
| 2012-09-30 | 310.00K shares 10-Q · filed 2013-11-14 | 310.00K shares 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | 310.00K shares 10-Q · filed 2013-08-14 | 310.00K shares 10-Q · filed 2013-08-14 | ||
| 2012-03-31 | 289.00K shares 10-Q · filed 2013-05-15 | |||
| 2011-12-31 | 570.00K shares 10-K · filed 2014-03-31 | |||
| 2011-09-30 | 176.00K shares 10-Q · filed 2012-11-14 | 176.00K shares 10-Q · filed 2012-11-14 | ||
| 2011-06-30 | 155.00K shares 10-Q/A · filed 2012-09-07 | 155.00K shares 10-Q/A · filed 2012-09-07 | ||
| 2010-12-31 | 355.00K shares 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |